Background In patients with ventricular dysfunction caused by stunning or hibernation, it is not clear when complete recovery of the salvaged myocardium occurs after acute myocardial infarction. The purpose of this study was to determine whether a delayed recovery of perfusion and contraction continues even after the subacute phase.
Background In patients with ventricular dysfunction caused by stunning or hibernation, it is not clear when complete recovery of the salvaged myocardium occurs after acute myocardial infarction. The purpose of this study was to determine whether a delayed recovery of perfusion and contraction continues even after the subacute phase.
Methods and Results We prospectively studied 71 consecutive male patients with first uncomplicated Q-wave anterior infarction. Resting regional blood flow distribution and contraction were assessed quantitatively 5 weeks and 7 months after the acute phase by serial sestamibi tomography and two-dimensional echocardiography. Coronary angiography also was performed in 52 patients. Overall, at 7 months there was an improvement in the perfusion defect severity (1019±811 versus 1365±821 at 5 weeks, P<.001) as well as in the extent of abnormal wall motion (28±19% versus 32±15%, P<.001) and left ventricular ejection fraction (53±14% versus 50±13%, P<.01). Among the 68 of 71 patients showing resting perfusion defects at 5 weeks, two groups were identified: 47 (group 1) who showed a significant (beyond the reproducibility limits) 7-month reduction of the resting perfusion defect, and 21 patients (group 2) in whom the perfusion defect remained unchanged. Ejection fraction and the extent of abnormal wall motion significantly (P<.01) improved in group 1 but not in group 2. Despite the presence of a comparable perfusion T he time course of the recovery of myocardial perfusion and function after myocardial infarction (MI) remains unclear. Although most improvement takes place within the first 7 to 14 days,1"2 myocardial dysfunction may persist well beyond this period despite adequate anterograde reperfusion, and some recovery occasionally is found up to 6 months thereafter.3-6 A possible explanation for the delayed recovery may be the presence of recurrent episodes of defect size between the two groups at 5 weeks after infarction, group 1 already showed a better regional and global ventricular function (P<.05). No significant differences were found between the two groups regarding age, medical therapy, the extent of underlying coronary disease, thrombolysis in the acute phase, Thrombolysis in Myocardial Infarction grade of the infarct-related vessel, and presence of collaterals on angiography.
Conclusions After anterior Q-wave infarction, the recovery of perfusion and wall motion may continue well after the subacute phase. Several patients exhibit relative hypoperfusion in viable tissue as late as 5 weeks after infarction, and a significant improvement of perfusion in the infarcted area commonly is observed between 5 weeks and 7 months. This delayed improvement of perfusion is associated with a delayed improvement of contractile function in the infarcted area after the first 5 weeks, which may continue for up to 7 months, suggesting the presence of hibemating myocardium in the infarcted area. Despite similar perfusion defect sizes, the level of regional function can be different at 5 weeks, and measurements taken around this time may not accurately estimate the eventual recovery of function. (Circulation. 1994; 90:1386 -1397 Key Words * myocardium * myocardial infarction .
reperfusion * isotopes subclinical ischemia, recurring myocardial stunning or, more likely, the presence of a flow-limiting residual stenosis that could cause myocardial dysfunction because of persistent hypoperfusion (hibernating myocardium).34 As a consequence, close evaluation of both regional perfusion and wall motion has been suggested to correlate these variables.3
9'Tc methoxy-isobutyl-isonitrile (sestamibi) is a myocardial perfusion agent whose uptake and retention are related to regional myocardial blood flow and tissue viability.7-10 It is considered a promising tool for assessing the risk area in acute MI and the efficacy of various reperfusion strategies. Changes in the extent and severity of the perfusion defect on serial sestamibi imaging after thrombolytic therapy have been used to estimate the amount of myocardial salvage and also have been related to the patency of the infarct-related artery. [11] [12] [13] [14] [15] [16] [17] Several studies have documented a strong correlation between the postintervention sestamibi defect size and the enzymatic estimates of infarct size16 as well as the regional and global left ventricular (LV) function.13 '17 The aim of this study was to assess the evolution of the sestamibi estimate of myocardial risk area in a selected population of patients with first Q-wave anterior MI; furthermore, we examined the relation between changes in the perfusion defect size and changes in global and regional ventricular function.
Methods Study Population and Protocol
The study population consisted of 71 consecutive male patients (49±8 years old) with recent anterior MI who met the following inclusion criteria: (1) history of recent (4 to 6 weeks) first Q-wave anterior MI, (2) sinus rhythm and no conduction disturbances, (3) no angina at rest, (4) New York Heart Association functional class I or II, and (5) two-dimensional echocardiographic images of quality adequate for quantitative analysis. The diagnosis of acute MI was supported by (1) typical history of chest pain (>30 minutes), (2) abnormal Q waves (>30 milliseconds) in at least two adjacent precordial leads and in leads I and/or aVL, and (3) a typical pattern of serum myocardial enzymes. Exclusion criteria were (1) systemic diseases, (2) severe LV dysfunction (resting ejection fraction <25%), (3) low-threshold ischemia or residual angina uncontrolled by medical therapy, and (4) inability to participate in a prospective study for any logistic reason.
In all patients, resting regional myocardial perfusion and LV function were assessed by sestamibi single-photon emission tomography and two-dimensional echocardiography, respectively, performed on the same day. The scintigraphic and echocardiographic studies were performed 4 to 6 weeks after the necrotic episode (T1) and then repeated 6 months later (T7). All patients had to be stable between the two studies. An additional intermediate echocardiographic evaluation was performed at 4 months after the infarction. Cardioactive drugs were discontinued at least 48 hours before each evaluation.
The study protocol was approved by the local ethical committee on human research. Informed consent was obtained from all patients.
Sestamibi Imaging
Sestamibi was prepared by adding a maximum of 80 mCi sterile nonpyrogenic sodium pertechnetate solution (1 to 3 mL) to a lyophilized kit; the vial was placed in a shielded boiling water bath for 10 minutes and then allowed to cool.
After the tracer injection (25 mCi/70 kg), a light meal was provided to the patients to accelerate the hepatobiliary clearance of the tracer and improve the heart-to-background ratio.
Scintigraphic images were obtained 90 to 120 minutes after the injection with a rotating camera (Apex 409, Elscint) equipped with a high-resolution, parallel-hole collimator. A ±10% energy window centered on the 140-keV photopeak was used. The camera head was rotated in a 1800 arc in a circular orbit from the 300 right anterior oblique to the 300 left posterior projection, with 30 increments of 25 seconds, in a step-and-shoot mode. Total acquisition time was 25 minutes. Data were collected in a 64x64 array with a pixel size of 4.5 mm. Particular care was taken to avoid major artifacts during the acquisition, such as patient motion.
Transaxial slices were reconstructed using a filtered backprojection algorithm with a modified Wiener filter with a 0.8 dumping factor, without attenuation or scatter correction; flood correction was applied during reconstruction. The spatial resolution in the transaxial plane was 8 mm. Short-axis and long-axis (horizontal and vertical) tomograms were reconstructed from the transaxial slices. All studies were processed by a single experienced operator (Dr Marcassa), who was unaware of the patients' clinical and functional data.
Short-axis slices were reconstructed from the transaxial sections, and polar maps of the regional sestamibi distribution were displayed. Each polar map was normalized for peak myocardial activity and compared with the normal limits obtained in 50 sex-matched subjects with <5% probability of coronary artery disease; pixels with tracer uptake falling more than 2.5 SD below mean normal values were considered abnormal.
The abnormal area on each short-axis slice first was multiplied by a correction factor'8 that takes into consideration differences in myocardial slice mass from apex to base and corrects for spatial distortion inherent in displaying a threedimensional volume two dimensionally. Corrected abnormal areas then were summed to obtain the total extent of the LV defect. The severity of a tracer uptake defect also was calculated: each pixel was assigned to categories expressing the degree below the reference value (from -2.5 SD, with 0.5-SD step). Pixels within the same SD category were summed and multiplied by a correction factor'8 that takes into account the SD category and the spatial distortion; values from all SD categories then were summed to obtain the total defect severity (expressed as arbitrary units).
In 20 patients (randomly selected from a group of 135 consecutive patients with Q-wave anterior MI who underwent sestamibi tomography in our laboratory), the sestamibi defect severity was obtained in duplicate fashion by repeating image processing and quantitative analysis after 2 weeks. The intraobserver variability of the method was assessed by linear regression analysis (regression line: y=0.97x+309; r=.98; P<.001). To assess changes in the perfusion defect from Ti to T7, the defect severity was considered, thus taking into account both the depth and extent of the perfusion defects. Reductions in the perfusion defect between the Ti and T7 studies were considered significant when changes in defect severity beyond the 95% confidence limits of the method variability were observed.
Echocardiographic Data Acquisition and Analysis
All patients underwent a complete echocardiographic study in multiple views (Hewlett-Packard 77020A); the positions of the patient and transducer were noted for use in serial studies. The method of data acquisition, image digitalization, and the computerized system for the automatic detection and quantification of regional wall motion and LV function have been described elsewhere.19-21 Briefly, the three apical views (four and two chambers and apical long-axis) were analyzed to assess ventricular function from three different planes and to explore six different ventricular walls from the base to the apex of the heart. The endocardial contour of each view was divided automatically into 23 segments of equal length, so that the entire ventricular wall was represented by a total of 69 segments. By comparison with our normal database, the presence of abnormal wall motion was detected automatically when the fractional shortening area from end diastole to end systole of each segment was less than 2 SD of the mean values in healthy subjects. The extent of wall motion abnormalities was expressed as a percentage of the total endocardial length (WMA%).
The LV ejection fraction (EF) was calculated with the biplane area-length method. All measurements were derived in blinded fashion by a single experienced operator (Dr Giannuzzi) from three consecutive cardiac cycles, and the mean values were considered. Intraobserver variability values in endocardial contouring and in the evaluation of end-systolic and end-diastolic endocardial surface area by our quantitative analysis in healthy subjects and in patients with MI have been reported. 19 
Coronary Angiography
According to the protocol design, cardiac catheterization was performed in the 6-month interval between the two scintigraphic (94) 3 (6) 36 (76) 13 (28) 5 (11) 5 (11) 5 (11) 38 (81) 3 (8) 25 (66) 10 (26) 8 (21) 10 (26) 2 (5) 18 (48) In segments exhibiting substantial improvement in wall motion at T7, the reduction in perfusion defect size could be partially accounted for by a partial volume effect37,38 whereby the perfusion defect may have been overestimated at Ti because of abnormal segmental contraction. However, such an explanation appears less likely, because a comparable perfusion defect size was seen in group 1 and 2 patients at Ti, despite the presence of a significantly different regional contraction.
Perfusion-Function Matching
To our knowledge, this is the first study demonstrating that regional myocardial function in the infarcted area can improve after the first 5 weeks following an acute infarction in a sizable number of patients. Several previous studies that examined the time course of recovery of myocardial function after reperfusion in acute MI found that regional function may improve significantly within daysl-3,6 but have not generally observed a further improvement after the first 2 weeks. Other studies evaluating serial changes in global LV function after coronary reperfusion were unable to document further improvement of LVEF at 341 or 12 months42 compared with the predischarge values. Overall, after coronary reperfusion the magnitude of the improvement in LV function is modest,41 and the changes in the extent of abnormal wall motion seem related more to the adequacy than to the timing of reperfusion.41,42 Our finding of a further improvement in function after the first 5 weeks is novel and intriguing.
Perhaps the most perplexing finding of this study was that at 5 weeks the myocardial contractile dysfunction was less severe in group 1 than in group 2 patients, despite the fact that their perfusion defects were similar. There are several possible explanations. First, there could be a difference in the time course of recovery between postischemic contractile impairment (myocardial stunning)3'43 and blood flow impairment (vascular stunning).33 In open-chest dogs subjected to a brief (15-minute) coronary occlusion followed by reflow, an impairment in resting flow was still present 4 hours after reperfusion, and this impairment did not correlate with the degree of impairment of mechanical performance in the postischemic myocardium.33 Second, it seems probable that group 2 patients had infarctions with a larger transmural extent than group 1 patients, as reflected by the higher peak creatine kinase levels. This could explain our observation that the extent of the sestamibi defect was similar in the two groups at 5 weeks, yet the WMAs were more pronounced in group 2 than in group 1. Although the size of the risk area was the same, the amount of viable tissue within the risk area could have been less in group 2 than in group 1. This would also explain why group 2 did not show any improvement in function (because most of the risk area was infarcted). Finally, the discrepancy between the perfusion defect and the regional function in groups 1 and 2 at 5 weeks might also reflect a difference in the degree of stunning [45] [46] [47] Clinical Implications
In our study, a significant improvement in sestamibi uptake in the infarcted area occurred spontaneously and concomitant with an improvement in regional and global ventricular function. The condition of initial hypoperfusion with subsequent concordant improvement in perfusion and function meets the definition of hibernating myocardium.4 Interestingly, in our study these changes were unrelated to the status of the infarct-related artery (patent versus occluded) or to the therapeutical approach in the acute phase (thrombolysis versus conventional treatment). Furthermore, the conventional definition of hibernating myocardium implies a flow restoration to the dysfunctional area secondary to an active revascularization procedure (ie, bypass or coronary angioplasty). In the population investigated, such a flow restoration occurred spontaneously. Thus, our study suggests that myocardial hibernation may be a common condition in the initial weeks or months after infarction.
Previous studies have demonstrated a strong correlation between predischarge sestamibi defect size at rest and LVEF and regional wall motion at the time of discharge,12,17 at 6 weeks,13'14 as well as at 1 year. 49 In our study, a significant inverse correlation was found between the defect severity and the LVEF and wall motion score 5 weeks after the event; this correlation was even stronger at the 7-month evaluation, particularly in those patients who showed a significant improvement in their sestamibi uptake. A similar pattern was observed for the correlation between Ti and T7 defect size and the peak creatine kinase level. The closer correlation between sestamibi defect size and conventional estimates of infarct size at 7 months suggests some overestimation of the true infarct size by sestamibi imaging at our first evaluation. The finding of some underestimation of the salvaged myocardium on sestamibi imaging performed 5 weeks after the infarction raises questions about whether an even earlier evaluation (ie, in the subacute phase or at predischarge) can accurately quantify the real extent of the scarred area. 
